Home Cart 0 Sign in  
X

[ CAS No. 35978-39-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 35978-39-3
Chemical Structure| 35978-39-3
Chemical Structure| 35978-39-3
Structure of 35978-39-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 35978-39-3 ]

Related Doc. of [ 35978-39-3 ]

Alternatived Products of [ 35978-39-3 ]

Product Details of [ 35978-39-3 ]

CAS No. :35978-39-3 MDL No. :MFCD00126441
Formula : C12H8N2OS Boiling Point : -
Linear Structure Formula :- InChI Key :OLGMRBGIXZANNV-UHFFFAOYSA-N
M.W : 228.27 Pubchem ID :215639
Synonyms :

Calculated chemistry of [ 35978-39-3 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 65.68
TPSA : 73.99 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.68
Log Po/w (XLOGP3) : 2.35
Log Po/w (WLOGP) : 2.65
Log Po/w (MLOGP) : 2.13
Log Po/w (SILICOS-IT) : 4.27
Consensus Log Po/w : 2.62

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.36
Solubility : 0.0988 mg/ml ; 0.000433 mol/l
Class : Soluble
Log S (Ali) : -3.54
Solubility : 0.0653 mg/ml ; 0.000286 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.03
Solubility : 0.00214 mg/ml ; 0.00000935 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.35

Safety of [ 35978-39-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 35978-39-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 35978-39-3 ]
  • Downstream synthetic route of [ 35978-39-3 ]

[ 35978-39-3 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 64-18-6 ]
  • [ 35978-39-3 ]
YieldReaction ConditionsOperation in experiment
92% at 130℃; for 6 h; Compound 6b (1 g, 5 mmol) was dissolved in 5 ml of formic acid as solvent,After stirring at room temperature, the temperature was raised to 130 ° C for 6 hours.After the reaction is completed, the solvent is dried,Add 200 ml of ethyl acetate and adjust the pH to neutral,Respectively, with saturated sodium bicarbonate,Saturated brine washing,Dried over anhydrous magnesium sulfate.Rotate the solvent to give a pink solid powder,Recrystallization from ethyl acetate gave a white solid powder 6c (1.05 g 92percent).
Reference: [1] Patent: CN107151240, 2017, A, . Location in patent: Paragraph 0190; 0191; 0192
  • 2
  • [ 4815-36-5 ]
  • [ 77287-34-4 ]
  • [ 35978-39-3 ]
Reference: [1] Synthetic Communications, 1996, vol. 26, # 20, p. 3733 - 3755
[2] European Journal of Medicinal Chemistry, 1984, vol. 19, # 5, p. 420 - 424
[3] European Journal of Medicinal Chemistry, 2011, vol. 46, # 3, p. 870 - 876
[4] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 22, p. 6662 - 6666
[5] European Journal of Medicinal Chemistry, 2016, vol. 115, p. 148 - 160
[6] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 18, p. 4339 - 4346
[7] Chemical Biology and Drug Design, 2017, vol. 90, # 6, p. 1115 - 1121
  • 3
  • [ 4815-36-5 ]
  • [ 3473-63-0 ]
  • [ 35978-39-3 ]
Reference: [1] Patent: WO2004/111057, 2004, A1, . Location in patent: Page 30
  • 4
  • [ 98-86-2 ]
  • [ 35978-39-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2016, vol. 115, p. 148 - 160
[2] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 18, p. 4339 - 4346
[3] Patent: CN107151240, 2017, A,
  • 5
  • [ 5447-87-0 ]
  • [ 35978-39-3 ]
Reference: [1] Patent: CN107151240, 2017, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 35978-39-3 ]

Aryls

Chemical Structure| 17537-74-5

[ 17537-74-5 ]

5-(2,4-Dimethylphenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 1.00

Chemical Structure| 331761-45-6

[ 331761-45-6 ]

5-(4-Chlorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.94

Chemical Structure| 307512-24-9

[ 307512-24-9 ]

5-(4-Bromophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.93

Chemical Structure| 35978-37-1

[ 35978-37-1 ]

5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.92

Chemical Structure| 294653-45-5

[ 294653-45-5 ]

2-Mercapto-5-phenylthieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.89

Amides

Chemical Structure| 17537-74-5

[ 17537-74-5 ]

5-(2,4-Dimethylphenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 1.00

Chemical Structure| 331761-45-6

[ 331761-45-6 ]

5-(4-Chlorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.94

Chemical Structure| 307512-24-9

[ 307512-24-9 ]

5-(4-Bromophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.93

Chemical Structure| 35978-37-1

[ 35978-37-1 ]

5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.92

Chemical Structure| 18593-44-7

[ 18593-44-7 ]

5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.92

Related Parent Nucleus of
[ 35978-39-3 ]

Other Aromatic Heterocycles

Chemical Structure| 17537-74-5

[ 17537-74-5 ]

5-(2,4-Dimethylphenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 1.00

Chemical Structure| 331761-45-6

[ 331761-45-6 ]

5-(4-Chlorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.94

Chemical Structure| 307512-24-9

[ 307512-24-9 ]

5-(4-Bromophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.93

Chemical Structure| 35978-37-1

[ 35978-37-1 ]

5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.92

Chemical Structure| 18593-44-7

[ 18593-44-7 ]

5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.92